INTRODUCTION {#s1}
============

Breast cancer is the most frequently diagnosed cancer globally and is the leading cause of cancer-related deaths among women \[[@R1]\]. In the United States, more than 240,000 newly diagnosed breast cancer cases and 40,000 deaths were reported in 2016 \[[@R2]\]. Liver metastasis is reported in 15% of newly diagnosed breast cancer patients \[[@R3], [@R4]\]. Breast cancer liver metastasis is associated with very poor prognosis and has a survival time of only 4-8 months, if untreated \[[@R5]\]. Introduction of new therapies in the last decade has resulted in 1-2% yearly decrease in mortality rates \[[@R6]\]. However, breast cancer patients with liver metastasis still are associated with very poor outcomes \[[@R7]\].

Metastatic disease is a complex, multistage process that involves detachment of breast cancer cells from the primary tumor, which then travel through the blood or lymphatic system and finally survive and proliferate in the liver. Given the complex multistep process, liver metastasis involves a sophisticated network of molecular events. However, the molecular mechanisms associated with breast cancer metastasis to the liver are unclear, and their understanding is essential for developing more effective therapies. In this study, therefore, we generated a genetic interaction network using microarray gene expression data from breast cancer liver metastases and explored the molecular mechanisms involved using bioinformatic analyses.

RESULTS {#s2}
=======

Forty-eight genes are differentially expressed in metastatic breast tumor cells {#s2_1}
-------------------------------------------------------------------------------

Table [1](#T1){ref-type="table"} lists the differentially expressed genes with a fold change ≥2 and false discovery rate ≤ 5%. There were 48 differentially expressed genes that were distinctly upregulated (4 genes) or downregulated (44 genes) in metastatic tumor cells than in normal parental cells. Figure [1](#F1){ref-type="fig"} shows the heat map of the differentially expressed genes.
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###### Significant genes identified by significant analysis of microarray (SAM) in liver-aggressive explant versus primary tumor explant

  Gene ID        Gene Name         Fold Change   Gene regulation
  -------------- ----------------- ------------- -----------------
  A_52_P618173   *Limch1*          2.290749902   Up
  A_52_P418791   *Rbp1*            2.424147188   Up
  A_51_P423484   *Rbp1*            2.165856946   Up
  A_52_P299915   *Map2k6*          2.176087369   Up
  A_51_P102538   *Otop1*           0.336723951   Down
  A_51_P289341   *Fermt1*          0.317362329   Down
  A_52_P452667   *Prom2*           0.285970233   Down
  A_51_P333923   *Tspan1*          0.315241505   Down
  A_51_P167489   *Lama3*           0.41612039    Down
  A_51_P177242   *Unc13b*          0.418318499   Down
  A_52_P88091    *Dsg2*            0.403969687   Down
  A_51_P233153   *Cadps2*          0.298078637   Down
  A_51_P196207   *Capsl*           0.388252581   Down
  A_52_P79821    *Esrp1*           0.26893644    Down
  A_52_P559779   *Dsg2*            0.347328438   Down
  A_51_P493987   *Moxd1*           0.417459194   Down
  A_52_P87757    *Il24*            0.336785971   Down
  A_52_P134455   *Fermt1*          0.367135842   Down
  A_51_P356055   *Grp*             0.449573589   Down
  A_51_P353252   *Mal2*            0.291415896   Down
  A_51_P187602   *Serpinb5*        0.3120555     Down
  A_52_P638605   *Ap1m2*           0.436913739   Down
  A_51_P105879   *Myo5b*           0.486596961   Down
  A_52_P405945   *Prl3d2*          0.483474132   Down
  A_51_P401517   *Il24*            0.483144818   Down
  A_52_P252931   *Dsc2*            0.491809463   Down
  A_52_P468068   *Tchh*            0.490774711   Down
  A_51_P322115   *Htr5b*           0.372641522   Down
  A_52_P286350   *Sh2d1b1*         0.471867312   Down
  A_52_P487686   *BC100530*        0.483518325   Down
  A_51_P489488   *Pde4dip*         0.487698119   Down
  A_51_P179293   *2310002L13Rik*   0.382311761   Down
  A_51_P322090   *Ovol2*           0.489037358   Down
  A_52_P661412   *Adora1*          0.485167002   Down
  A_52_P683580   *Tbc1d9*          0.471654273   Down
  A_51_P206475   *Lce1i*           0.476512201   Down
  A_51_P496540   *Sh2d1b1*         0.488430246   Down
  A_52_P601757   *Dsg2*            0.414988774   Down
  A_51_P496253   *Slc6a4*          0.464974691   Down
  A_51_P438283   *Il1a*            0.497937489   Down
  A_51_P455620   *Fam167a*         0.45781262    Down
  A_51_P332309   *Eomes*           0.434829918   Down
  A_51_P225827   *Ovol1*           0.474676527   Down
  A_51_P338878   *P2ry12*          0.424196491   Down
  A_52_P373982   *Grhl2*           0.481346604   Down
  A_52_P642488   *Kcnk1*           0.43461204    Down
  A_51_P303079   *Tmem54*          0.492962995   Down
  A_51_P362328   *Grhl2*           0.469572322   Down

**Abbreviation:** SAM, Significance Analysis Microarray

A genetic interaction network based on the differently expressed genes {#s2_2}
----------------------------------------------------------------------

A genetic interaction network was constructed from the 48 differentially expressed genes using the String platform future analysis (Figure [2](#F2){ref-type="fig"}). The interaction network consisted of 84 nodes and 237 edges. The average node degree was 5.64. The network was reliably robust with a clustering coefficient (cc) of 0.598 and protein-protein interaction (PPI) enrichment *p* value of zero.
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GO analysis of the differently expressed genes {#s2_3}
----------------------------------------------

Molecular function analysis by the GO con-sortium database revealed that most of the differently expressed genes regulated protein binding and kinase activity (Table [2](#T2){ref-type="table"}). Besides, the major biological processes associated with the liver metastases were positive regulation of cell communication, MAPK cascade, signaling, and protein kinase activity (Table [3](#T3){ref-type="table"}).

###### Molecular function analysis of the genetic interaction network associated with liver-aggressive explant in terms of Gene Ontology (GO)

  GO ID        Molecular Function                                                                           Observed Gene Count   *FDR*
  ------------ -------------------------------------------------------------------------------------------- --------------------- ----------
  GO.0004702   receptor signaling protein serine/threonine kinase activity                                  15                    3.13E-21
  GO.0005515   protein binding                                                                              7                     2.03E-05
  GO.0004708   MAP kinase kinase activity                                                                   41                    2.41E-05
  GO.0017137   Rab GTPase binding                                                                           5                     2.74E-05
  GO.0031489   myosin V binding                                                                             6                     0.000307
  GO.0017022   myosin binding                                                                               4                     0.000381
  GO.0004709   MAP kinase kinase kinase activity                                                            5                     0.000518
  GO.0005488   binding                                                                                      4                     0.00169
  GO.0017075   syntaxin-1 binding                                                                           59                    0.00354
  GO.0004707   MAP kinase activity                                                                          3                     0.00402
  GO.0004674   protein serine/threonine kinase activity                                                     3                     0.00636
  GO.0004946   bombesin receptor activity                                                                   9                     0.0113
  GO.0005102   receptor binding                                                                             2                     0.0128
  GO.0004908   interleukin-1 receptor activity                                                              14                    0.018
  GO.0019905   syntaxin binding                                                                             2                     0.0215
  GO.0019899   enzyme binding                                                                               4                     0.0253
  GO.0004871   signal transducer activity                                                                   15                    0.032
  GO.0005179   hormone activity                                                                             16                    0.0377
  GO.0060089   molecular transducer activity                                                                4                     0.0377
  GO.0086083   cell adhesive protein binding involved in bundle of Hiscell-Purkinje myocyte communication   17                    0.0377

Abbreviations: FDR, false discovery rate; GO, Gene Ontology.

###### Biological process analysis of the genetic interaction network associated with liver-aggressive explant in terms of Gene Ontology (GO)

  GO ID        Biological Process                                 Observed Gene Count   *FDR*
  ------------ -------------------------------------------------- --------------------- ----------
  GO.0051046   regulation of secretion                            21                    5.45E-10
  GO.0080134   regulation of response to stress                   28                    6.97E-10
  GO.1903530   regulation of secretion by cell                    19                    4.53E-09
  GO.0051047   positive regulation of secretion                   15                    8.72E-09
  GO.0032101   regulation of response to external stimulus        20                    1.24E-07
  GO.0032879   regulation of localization                         31                    1.24E-07
  GO.0051049   regulation of transport                            27                    1.24E-07
  GO.0051050   positive regulation of transport                   20                    1.24E-07
  GO.0031347   regulation of defense response                     18                    3.95E-07
  GO.0010647   positive regulation of cell communication          25                    4.18E-07
  GO.0060341   regulation of cellular localization                22                    4.18E-07
  GO.0043410   positive regulation of MAPK cascade                14                    8.81E-07
  GO.0014047   glutamate secretion                                6                     1.17E-06
  GO.0050690   regulation of defense response to virus by virus   6                     1.38E-06
  GO.0023056   positive regulation of signaling                   23                    1.79E-06
  GO.0051650   establishment of vesicle localization              10                    2.00E-06
  GO.0046717   acid secretion                                     7                     3.36E-06
  GO.0001934   positive regulation of protein phosphorylation     17                    5.02E-06
  GO.0016079   synaptic vesicle exocytosis                        37                    3.10E-13
  GO.0045860   positive regulation of protein kinase activity     11                    3.55E-13

Abbreviations: FDR, false discovery rate; GO, Gene Ontology; MAPK: mitogen-actived protein kinase.

Signaling pathways involved in breast cancer liver metastasis {#s2_4}
-------------------------------------------------------------

Table [4](#T4){ref-type="table"} shows the signaling pathways involved in breast cancer liver metastases by the KEGG database. The major signaling pathways included the MAPK, NF-kappa B and VEGF signaling pathways that maybe critical for the distinct pathological stages of liver metastasis.

###### Signaling pathway analysis of the genetic interaction network associated with liver-aggressive explant in terms of Gene Ontology (GO)

  Pathway ID   Signaling pathway                                            Observed Gene Count   *FDR*
  ------------ ------------------------------------------------------------ --------------------- ----------
  4010         MAPK signaling pathway                                       16                    1.42E-12
  4668         TNF signaling pathway                                        9                     7.29E-08
  5014         Amyotrophic lateral sclerosis (ALS)                          7                     1.26E-07
  4750         Inflammatory mediator regulation of TRP channels             8                     3.45E-07
  4380         Osteoclast differentiation                                   8                     1.45E-06
  5140         Leishmaniasis                                                6                     1.24E-05
  4721         Synaptic vesicle cycle                                       5                     0.000104
  4664         Fc epsilon RI signaling pathway                              5                     0.000156
  4660         T cell receptor signaling pathway                            5                     0.000787
  5146         Amoebiasis                                                   5                     0.000993
  4060         Cytokine-cytokine receptor interaction                       7                     0.00133
  4722         Neurotrophin signaling pathway                               5                     0.00145
  5160         Hepatitis C                                                  5                     0.00206
  4015         Rap1 signaling pathway                                       6                     0.00207
  4911         Insulin secretion                                            4                     0.00355
  4728         Dopaminergic synapse                                         4                     0.0148
  5131         Shigellosis                                                  3                     0.0148
  4370         VEGF signaling pathway                                       3                     0.0155
  5162         Measles                                                      4                     0.0162
  5120         Epithelial cell signaling in Helicobacter pylori infection   3                     0.0194
  5222         Small cell lung cancer                                       3                     0.0351
  4064         NF-kappa B signaling pathway                                 3                     0.0384
  5168         Herpes simplex infection                                     4                     0.0384
  4723         Retrograde endocannabinoid signaling                         3                     0.0473

Abbreviations: FDR, false discovery rate; GO, Gene Ontology.

DISCUSSION {#s3}
==========

Breast cancer liver metastasis is a complex process that includes tumor cell dissemination from the primary tumor, transit through the blood or lymphatic system, and proliferation in liver. Underlying this complex multistep process is a sophisticated network of molecular events. In this study, we generated, for the first time, a comprehensive genetic interaction network from the microarray gene expression profile to identify the molecular mechanisms involved in breast cancer liver metastases. The results suggested that MAPK, NF-kappa B and VEGF signaling pathways are significantly associated with distinct stages of breast cancer liver metastasis.

Dissemination of carcinoma cells is the initial step of the metastasis, which is initiated by epithelial-mesenchymal transition (EMT) program during which tumor cells acquire mesenchymal features and lose epithelial properties \[[@R8], [@R9]\]. The complex molecular events during EMT are initiated and controlled by signaling pathways that respond to extracellular cues. The transforming growth factor-β (TGF-β) signaling family plays a predominant role in EMT \[[@R10]\]. Moreover, the MAPK signaling pathway is required for the initiation of TGF-β induced EMT \[[@R11], [@R12]\]. In addition to TGF-β family proteins, tyrosine kinase receptors (RTKs) play a key role in the trans-differentiation process, further highlighting the importance of MAPK signaling \[[@R13]\]. MAPK pathway inhibitors have been used clinically for many cancers, including breast cancer \[[@R14]\]. In addition, NFκB is an important regulator of the expression of various proteins involved in the immune response \[[@R15]\].

After successfully disassociating from the primary tumor, metastatic carcinoma cells traverse the blood or lymphatic system, during which they interact with several cell types including platelets, neutrophils, monocytes, macrophages, and endothelial cells \[[@R16]\]. The circulating tumor cells also interact with platelets \[[@R17]\] and high platelet counts are associated with poor prognosis in carcinomas \[[@R18]\]. Recent studies have revealed that platelets alter the fate of circulating cancer cells \[[@R19]\]. Platelet-tumor cell contacts and platelet-derived TGF-β synergistically activate the TGF-β/Smad and NFκB pathways in cancer cells enabling their transition to an invasive mesenchymal-like phenotype, thereby enhancing metastasis \[[@R20]\]. Inhibition of NFκB signaling in cancer cells or ablation of TGF-β1 expression in platelets protects against lung metastasis *in vivo* \[[@R20]\].

In the liver, a pre-metastatic niche is established by VEGFR^+^ bone marrow progenitors before the arrival of tumor cells \[[@R21]\]. In fact, the initial events during the development of metastasis are VEGF-dependent \[[@R22]\]. Once the metastatic cancer cells survive in the new environment, they undergo colonization before the onset of the final process of malignancy. In general, a tumor requires angiogenesis to grow beyond 1-2 mm in size. In the initial pre-vascular phase, the size of the tumor does not exceed a few millimeters, but, neo-vascularization results in rapid growth of the tumor. Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis, which stimulates endothelial proliferation and migration, inhibits endothelial apoptosis, and increases vascular permeability and vasodilatation \[[@R23]\]. VEGF-targeting therapy has shown significant benefits in the treatment of metastatic breast cancer \[[@R24], [@R25]\]. In conclusion, based on the genetic interaction network, we identified MAPK, NF-kappa B and VEGF signaling pathways as key regulators of breast cancer liver metastasis.

MATERIALS AND METHODS {#s4}
=====================

Microarray dataset resources {#s4_1}
----------------------------

Microarray dataset with the accession number GSE62598 was downloaded from Gene Expression Omnibus (GEO). In this study, the authors examined if the propensity of breast cancer cells to metastasize to liver was associated with distinct patterns of immune cell infiltration \[[@R26]\]. Total RNA was extracted from 4T1 parental and individual metastatic sub-populations. The mRNA array was performed on Agilent-014868 Whole Mouse Genome Microarray 4×44k G4122F platform.

Analysis of differentially expressed genes {#s4_2}
------------------------------------------

The gene expression profiles of metastatic tumor cells versus disseminated tumor cells were normalized by log~10~ transformation after normalization. Then, Significance Analysis of Microarrays software (SAM, <http://statweb.stanford.edu/~tibs/SAM/>) was used to produce a cluster of up- or down-regulated genes \[[@R27]\].

Genetic interaction network construction {#s4_3}
----------------------------------------

Genetic interaction network was constructed using the String consortium database (<http://string-db.org/>). In addition, to identify the pathways involved Gene Ontology consortium (GO, <http://www.geneontology.org/>) and Kyoto Encyclopedia of Genes and Genomes (KEGG, <http://www.genome.jp/kegg/>) functional enrichment analysis was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID, <https://david.ncifcrf.gov/>).

Statistical analysis {#s4_4}
--------------------

According to a previous publication \[[@R28]\], gene expression was considered significant if the threshold of false discovery rate (FDR) ≤ 5% and fold change ≥ 2. For GO and KEGG enrichment analysis, biological process, molecular function and signaling pathways, *p* ≤ 5% was considered significant.
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